Regulatory › Drugs@FDA › History › NDA217806 Drugs@FDA application timeline
NDA217806 13 dated FDA-coded AP submissions from 2023-11-08 through 2026-02-25, connected to 21 source-defined action assignments and 33 official document links.
13 Dated AP submissions
21 Action assignments
33 Official documents
0 Exact enforcement reports
1 Reviewed profile mappings
Reporting boundary This history reports exact Drugs@FDA submission status dates, source-defined action labels, and official document metadata for applications already selected by PeptideScanner. FDA's AP code and action labels are source metadata; this page does not interpret approval scope, reproduce document text, establish safety or effectiveness, or provide medical guidance. Document links open FDA-hosted material; PeptideScanner does not copy or summarize their contents.
Reviewed identity mapping
Connected peptide profiles Newest first
Submission and document chronology 13 submissions 2026-02-25 · status AP
Supplement 42 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2026-03-02 · FDA document 85191 Letter ↗ 2026-02-27 · FDA document 85180 2026-01-20 · status AP
Supplement 2 FDA action labels Labeling-Container/Carton Labels · Labeling-Medication Guide · Labeling-Package Insert
4 official documents 2026-01-07 · status AP
Supplement 37 FDA action labels Manufacturing (CMC)-Formulation
3 official documents 2025-09-25 · status AP
Supplement 31 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Label ↗ 2025-09-26 · FDA document 83555 Letter ↗ 2025-09-26 · FDA document 83542 2025-02-07 · status AP
Supplement 20 FDA action labels Labeling-Container/Carton Labels · Labeling-Package Insert
2 official documents Label ↗ 2025-02-10 · FDA document 81191 Letter ↗ 2025-02-10 · FDA document 81181 2024-12-20 · status AP
Supplement 13 FDA action labels Efficacy-New Indication
4 official documents 2024-10-18 · status AP
Supplement 19 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Label ↗ 2024-10-21 · FDA document 79938 Letter ↗ 2024-10-21 · FDA document 79930 2024-10-18 · status AP
Supplement 15 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
2 official documents Label ↗ 2024-10-21 · FDA document 79952 Letter ↗ 2024-10-21 · FDA document 79929 2024-10-18 · status AP
Supplement 11 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2024-10-21 · FDA document 79937 Letter ↗ 2024-10-21 · FDA document 79928 2024-10-18 · status AP
Supplement 6 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Label ↗ 2024-10-21 · FDA document 79936 Letter ↗ 2024-10-21 · FDA document 79925 2024-10-18 · status AP
Supplement 5 FDA action labels Labeling-Medication Guide · Labeling-Package Insert
3 official documents Label ↗ 2024-10-21 · FDA document 79935 Letter ↗ 2024-10-21 · FDA document 79927 Letter ↗ 2024-10-21 · FDA document 79926 2024-03-28 · status AP
Supplement 3 FDA action labels Labeling-Container/Carton Labels · Labeling-Medication Guide · Labeling-Package Insert
2 official documents Letter ↗ 2024-04-03 · FDA document 78043 Label ↗ 2024-04-01 · FDA document 78015 2023-11-08 · status AP
Original submission 1 No source action-type assignment was retained for this submission.
3 official documents Review ↗ 2024-04-16 · FDA document 78149 Letter ↗ 2023-11-13 · FDA document 76547 Label ↗ 2023-11-08 · FDA document 76538 Source archive dated 2026-08-24; observed 2026-08-24T21:23:49.000Z; reviewed 2026-08-24. Observation SHA-256: 6166fd223ef126a19e8ebfdaafe1fbf7c330a4cf7153cef00fb6c52c45ef757b.